Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis

Yu-Ting Lin,1 Tamara Will,2 Charlotte Wickham,3 Petra Boeree,2 Dominic Jack,4 Matthew Keiser1,5 1Device and Connected Solution Engineering, Global Healthcare Operations, Ares Trading SA (an affiliate of Merck KGaA), Eysins, Switzerland; 2Human Factors Research & Design, Emergo by UL, Utrecht, th...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Patient Preference and Adherence
المؤلفون الرئيسيون: Lin YT, Will T, Wickham C, Boeree P, Jack D, Keiser M
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Dove Medical Press 2023-08-01
الموضوعات:
rebismart electromechanical autoinjector
adherence
interferon beta-1a
multiple sclerosis
الوصول للمادة أونلاين:https://www.dovepress.com/evolution-of-the-rebismart-electromechanical-autoinjector-to-improve-u-peer-reviewed-fulltext-article-PPA

الانترنت

https://www.dovepress.com/evolution-of-the-rebismart-electromechanical-autoinjector-to-improve-u-peer-reviewed-fulltext-article-PPA

مواد مشابهة